{"id":"W4410804753","doi":"10.1200/jco.2025.43.16_suppl.tps8666","title":"Neladalkib (NVL-655), a highly selective anaplastic lymphoma kinase (ALK) inhibitor, compared to alectinib in first-line treatment of patients with ALK-positive advanced non-small cell lung cancer: The phase 3 ALKAZAR study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Alectinib; Anaplastic lymphoma kinase; Medicine; ALK inhibitor; Crizotinib; Cancer research; Lung cancer; Kinase; Lymphoma; Cancer; Oncology; Pathology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008975579,0.0009677971,0.001330861,0.0003421939,0.0001944907,0.0009044334,0.0005385744,0.0009127546,0.002283722],"category_scores_gemma":[0.0006216185,0.0003998894,0.001996196,0.0002858254,0.0004396702,0.0005922102,0.0002746507,0.002478923,0.0005500254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007355304,"about_ca_system_score_gemma":0.0007721169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008962328,"about_ca_topic_score_gemma":0.003442593,"domain_scores_codex":[0.9997787,0.00009212692,0.00001390116,0.00004052929,0.00002730113,0.00004740556],"domain_scores_gemma":[0.9996328,0.00005988797,0.0001015551,0.00001859997,0.00002262491,0.0001644958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8043448,0.01948027,0.01030189,0.001481809,0.004077775,0.0002275318,0.000230394,0.002196722,0.0374414,0.0002428035,0.004248627,0.115726],"study_design_scores_gemma":[0.5823373,0.3547114,0.04587845,0.0001492833,0.00331752,0.0007323001,0.0001250048,0.002009642,0.004915186,0.0003128512,0.005444819,0.00006616439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859881,0.00963386,0.0002608844,0.0005335833,0.0001845882,0.0005726176,0.000979648,0.0000846937,0.00176215],"genre_scores_gemma":[0.9910836,0.003839421,0.0004632612,0.0007497093,0.00009957009,0.0003480289,0.001340397,0.0000169501,0.002059002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002283722,"threshold_uncertainty_score":0.007639825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02437227647703226,"score_gpt":0.4274987139296226,"score_spread":0.4031264374525903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}